Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1245536.RAwmt1HK8RVICT_FG4NUqJ6zrn_4mGDJapxhHBvOAO93w130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1245536.RAwmt1HK8RVICT_FG4NUqJ6zrn_4mGDJapxhHBvOAO93w130_assertion type Assertion NP1245536.RAwmt1HK8RVICT_FG4NUqJ6zrn_4mGDJapxhHBvOAO93w130_head.
- NP1245536.RAwmt1HK8RVICT_FG4NUqJ6zrn_4mGDJapxhHBvOAO93w130_assertion description "[Overall results suggest that phosphorylated HER3, ERK1/2 and p53 may be used as biomarkers to determine the sensitivity of bladder cancers to TKIs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1245536.RAwmt1HK8RVICT_FG4NUqJ6zrn_4mGDJapxhHBvOAO93w130_provenance.
- NP1245536.RAwmt1HK8RVICT_FG4NUqJ6zrn_4mGDJapxhHBvOAO93w130_assertion evidence source_evidence_literature NP1245536.RAwmt1HK8RVICT_FG4NUqJ6zrn_4mGDJapxhHBvOAO93w130_provenance.
- NP1245536.RAwmt1HK8RVICT_FG4NUqJ6zrn_4mGDJapxhHBvOAO93w130_assertion SIO_000772 25482142 NP1245536.RAwmt1HK8RVICT_FG4NUqJ6zrn_4mGDJapxhHBvOAO93w130_provenance.
- NP1245536.RAwmt1HK8RVICT_FG4NUqJ6zrn_4mGDJapxhHBvOAO93w130_assertion wasDerivedFrom befree-2016 NP1245536.RAwmt1HK8RVICT_FG4NUqJ6zrn_4mGDJapxhHBvOAO93w130_provenance.
- NP1245536.RAwmt1HK8RVICT_FG4NUqJ6zrn_4mGDJapxhHBvOAO93w130_assertion wasGeneratedBy ECO_0000203 NP1245536.RAwmt1HK8RVICT_FG4NUqJ6zrn_4mGDJapxhHBvOAO93w130_provenance.